The number 13 of the family: a proliferation inducing ligand
- 16 August 2021
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 71, 132-137
- https://doi.org/10.1016/j.coi.2021.06.018
Abstract
No abstract availableKeywords
Funding Information
- Fondation ARSEP
- ANR
This publication has 58 references indexed in Scilit:
- The TNF family member APRIL dampens collagen-induced arthritisAnnals Of The Rheumatic Diseases, 2012
- Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset MonkeysJournal of Neuroimmune Pharmacology, 2012
- Selective APRIL Blockade Delays Systemic Lupus Erythematosus in MousePLOS ONE, 2012
- Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trialArthritis Research & Therapy, 2012
- Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 miceArthritis & Rheumatism, 2011
- B Cell Maturation Antigen Deficiency Exacerbates Lymphoproliferation and Autoimmunity in Murine LupusThe Journal of Immunology, 2011
- Therapeutic effects of TACI-Ig on rat with adjuvant arthritisClinical and Experimental Immunology, 2010
- B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B cell maturation antigen-immunoglobulinArthritis Research & Therapy, 2010
- Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiationJournal of Allergy and Clinical Immunology, 2007
- Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferationCell Death & Differentiation, 2005